Skip to main content

Glipizide

NDC 71610-175 · Aphena Pharma Solutions - Tennessee, LLC

Generic nameGlipizide
Dosage formTABLET
RouteORAL
Active ingredient(s)GLIPIZIDE
Strength5 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

71610-175-45 — 45 TABLET in 1 BOTTLE (71610-175-45)

71610-175-60 — 90 TABLET in 1 BOTTLE (71610-175-60)

71610-175-80 — 180 TABLET in 1 BOTTLE (71610-175-80)

71610-175-92 — 270 TABLET in 1 BOTTLE (71610-175-92)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71335-1042 — Glipizide, 71335-1130 — Glipizide, 71335-2353 — Glipizide, 71335-2520 — Glipizide, 71335-2528 — Glipizide, 71335-2540 — Glipizide, 71335-3133 — Glipizide, 71335-9614 — Glipizide, 71335-9742 — Glipizide, 71610-105 — Glipizide, 71610-668 — Glipizide, 71610-680 — Glipizide, 72162-2102 — Glipizide, 72162-2103 — Glipizide, 72162-2215 — Glipizide, 72162-2614 — Glipizide, 72789-130 — Glipizide, 72789-463 — Glipizide, 72789-464 — Glipizide, 72789-510 — Glipizide, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels